StatusFlow

References and packagings:

StatusFlow is a stable preparation of human peripheral leukocytes and erythrocytes designed for use as a control in immunophenotyping when evaluating RBC lysis, antibody reactivity, instrument set-up, and instrument performance by flow cytometry. Assay values are reported as a percent of total lymphocytes and as the number of cells for the following phenotypes : CD3+, CD3+/CD4+, CD3+/CD8+, CD19+, CD3-/CD16+56+, CD20+, CD2+,  and HLA-DR+. Target values (for research use only) are also provided for the following CD markers : kappa, lambda, CD8+/CD38+, CD33+/CD14+, CD7+/CD3+, CD5+, CD22+/CD3-, and CD13+. Target values for CD45 and CD14, which are intented for gating purposes only, are also included. StatusFlow has a closed vial stability of 45 days with an open vial stability of 9 thermal cycles. Each new lot is shipped every month. StatusFlow exists in 2.5 and 4.0 mL hemogard tube.

Description

Références

0FC010TA2

1 Tube of 2.5 ml

0FC020TA2

2 Tubes of 2.5 ml

0FC030TA2

3 Tubes of 2.5 ml

(Flow Cytometry Control)

0FC010TA4

1 Tube of 4.0 ml

0FC020TA4

2 Tubes of 4.0 ml

0FC040TA4

4 Tubes of 4.0 ml

0FC040TA2

4 Tubes of 2.5 ml